Abbott ABT announced the availability of FreeStyle LibreLink app in Europe for use in smartphones(both iPhone and Android). Notably, diabetes patients using the ...
Using near-field communication (NFC) technology, the app transfers glucose data from the sensor to the mobile device, allowing users to track their eight-hour glucose history and real-time patterns ...
MISSISSAUGA, Ontario, Oct. 4, 2018 /CNW/ -- Abbott (NYSE: ABT) announced today the company has received the Health Canada license of its FreeStyle LibreLink mobile app for use with compatible iOS ...
Abbott on Thursday launched its digital health tool, FreeStyle LibreLink app in India. The mobile app allows people who use the FreeStyle Libre system to measure their glucose readings on their mobile ...
Nearly two years after going live in Europe, the latest version of Abbott’s FreeStyle Libre continuous glucose monitor is ready to make its stateside debut. The FDA cleared the FreeStyle Libre 3 ...
The FDA has escalated the recall of specific Abbott FreeStyle Libre 3 and 3 Plus CGMs to Class I, the highest level of ...
The Food and Drug Administration (FDA) has now identified the previous recall of certain FreeStyle Libre glucose monitor ...
MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results